Pr. Agnès Buzyn
|
Pr. Agnès Buzyn is an hematologist at the chidrens'hospital Hopital Necker-Enfants Malades in Paris . She is a member of the board of directors of the CML group Fi LMC. |
La nomination du Pr Agnès Buzyn à la présidence de l'INCa ne devrait plus tarder
May 11, 2011, Cancerbretagne.net
Phase II Prospective Multicenter Study of Treosulfan Based Reduced Intensity Conditioning In Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies From 10/10 HLA Identical Unrelated Donor
December 5, 2010, ASH2010
The Use of Bone Marrow Graft for Hematopoietic Stem Cell Transplantation From Matched Unrelated Donors After Reduced Intensity Conditioning Regimen Improves Survival : Analysis of the Societe Française De Greffe De Moelle Et De Therapie Cellulaire
December 8, 2009, ASH2009
Low non-relapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma: Report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
September 7, 2009, Bio Info Banj Library
Imatinib in combination with cytarabine for the treatment of Philadelphia-positive chronic myelogenous leukemia chronic-phase patients: Rationale and design of phase I/II trials
April 2003, Seminar in hematology
